Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A petri dish with cell culture on a lab bench

Jun 4, 2026

Scispot closes $8-million USD Series A to become the operating layer for life sciences labs

Kitchener-Waterloo-based Scispot has successfully raised $8 million USD in Series A funding aimed at revolutionizing life sciences labs with AI technology.The company is focused on streamlining the often disjointed processes in life sciences research, including experiment planning, execution, documentation, and inventory management. Scispot's platform enables labs to centralize and automate these tasks, which is particularly beneficial for drug development and pathology research. Co-founder and
A minimalist illustration of a chromosome and genome strand representing advancements in genomics research.

Jun 4, 2026

OpenAI GPT-Rosalind Update Brings Advanced AI Drug Discovery and Genomics Research Capabilities

OpenAI has unveiled a major update to its GPT-Rosalind model, enhancing its capabilities in drug discovery and genomics research.The June 3, 2026 announcement highlights advancements in the GPT-Rosalind series, which is tailored for life sciences research, particularly in drug discovery and genomics. This update integrates the sophisticated features of GPT 5.5, aiming to improve performance in critical areas such as medicinal chemistry and experimental biology. OpenAI emphasizes that progress in
An RNA molecule on a lab bench in a dimly lit laboratory setting.

Jun 4, 2026

AI Collaboration Puts Alnylam’s RNAi Pipeline Productivity In Focus

Alnylam Pharmaceuticals has entered a collaboration with Inceptive Nucleics to enhance RNA interference (RNAi) drug discovery through the application of generative AI models. This partnership aims to streamline the drug design process, potentially increasing the efficiency and speed of developing new therapeutics as part of Alnylam's broader strategy for 2030.The collaboration seeks to leverage Inceptive's expertise in AI to optimize RNAi drug design, thereby shortening the trial-and-error phase
A gear and arrow symbolizing industrial strength and investment in AI.

Jun 4, 2026

German VC Merantix Capital closes €103M, its largest fund yet, to turn Europe's industrial strengths into AI champions

Merantix Capital has successfully closed its largest fund to date, raising €103 million to support early-stage AI startups across Europe, particularly in sectors like logistics, healthcare, and manufacturing.The newly established fund aims to invest in approximately 40 AI-native companies, with backing from a diverse group of limited partners, including Union Investment and KPMG Germany. This initiative reflects a growing recognition of the potential for European startups to leverage the contine
An open scientific journal in a dimly lit research lab, symbolizing collaboration in life sciences.

Jun 4, 2026

How bio:cap is reconnecting Europe’s life sciences ecosystem

The bio:cap initiative aims to enhance collaboration within Europe's fragmented life sciences ecosystem.Europe has a rich history in scientific research, bolstered by esteemed institutions and a skilled workforce. Despite significant investments—€3.6 billion in biotech in 2025 and €4.3 billion in drug discovery—the life sciences sector faces challenges due to fragmentation. Lara Formichella, project lead for bio:cap, emphasizes that researchers, investors, and industry leaders often operate in s
Interior view of a modern car dashboard

Jun 4, 2026

Vodafone and Geely extend deal for in-car digital services

Vodafone and Geely Technology Europe have solidified their partnership to enhance vehicle connectivity, focusing on in-car digital services and secure data infrastructure.The collaboration aims to expand Vodafone's Internet in the Car, Mobile Private Networks, and Cloud Connect offerings, which already support diagnostics and over-the-air software updates for Geely’s vehicles in Europe. This initiative allows for compliant internet access across over 30 countries, improving in-vehicle infotainme
A minimalist illustration of a microphone representing biotech leaders' discussion.

Jun 4, 2026

Facing pressure from China, BioSpace’s NextGen biotech leaders say: ‘Bring it on’

In a recent discussion, leaders from the biotech sector emphasized the need for American firms to adopt a proactive stance in the face of increasing competition from China. They believe that U.S. innovations can stand strong in the global market, but strategic support from government and industry is crucial.During a BioSpace webinar, Mo Trikha, CEO of Kivu Bioscience, expressed a confident outlook on competition, urging the biotech community to embrace challenges from Chinese firms. Alongside hi
A data sheet and pen on a wooden desk in a clinical office setting.

Jun 4, 2026

Triomics Secures $22M for Cancer Data AI

Triomics has successfully raised $22 million in Series B funding to enhance its AI platform aimed at improving oncology data management and patient care.The funding round, led by Battery Ventures, includes contributions from existing investors such as Nexus Venture Partners, Lightspeed, and Y Combinator, as well as new strategic partners like Oncology Ventures and Precision Health Informatics. This investment elevates Triomics' total funding to over $36 million, enabling the company to expand it
Illustration of a T cell interacting with a tumor cell in a minimalist style.

Jun 4, 2026

Why Oncolytics Biotech (ONCY) Is Up 14.5% After New Pelareorep RAS-Tumor Immune Activation Data

Oncolytics Biotech has recently seen a 14.5% increase in stock value following promising new data on its drug pelareorep, which shows enhanced anti-tumor activity in RAS-driven solid tumors such as pancreatic and breast cancer.The recent preclinical findings indicate that pelareorep can boost the activity of virus- and tumor-specific T cells, engage immune responses targeting KRAS, and potentially work well with next-generation RAS inhibitors. This data is crucial as it may influence future clin
Anastomotic leak detection device in an operating room

Jun 4, 2026

Qaelon Medical and Scialytics Announce Data Strategy Partnership to Advance AI‑Driven Surgical Intelligence in Colorectal Surgery

Qaelon Medical and Scialytics have formed a strategic partnership aimed at enhancing AI-driven surgical intelligence in colorectal surgery. This collaboration seeks to integrate Qaelon's real-time physiological gastrointestinal data into Scialytics' advanced surgical analytics platform, marking a significant step towards creating a more intelligent medtech ecosystem.The partnership addresses the critical issue of anastomotic leaks, a serious complication in colorectal surgeries that can occur at
A minimalist representation of a pill and a molecule symbolizing drug discovery.

Jun 3, 2026

Nxera Pharma: Obesity pipeline advances, commercial growth, and AI-driven discovery fuel strategic momentum

Nxera Pharma is making notable strides in its obesity and rare disease pipelines, showcasing advancements in novel oral small molecules and the potential for out-licensing key assets.The company's commercial growth is particularly evident in Japan, where they have achieved significant milestone income. This success is bolstered by the introduction of a new AI-driven drug discovery platform, which is integral to their strategy aimed at specialty and rare diseases.This momentum reflects Nxera's co
A DNA sequencing sample on a lab bench with a pipette

Jun 3, 2026

AI tool simplifies and scales complete genome assembly, supporting advances in diagnostics and precision medicine

An innovative AI tool called HERRO has been developed to enhance the accuracy and efficiency of complete genome assemblies, potentially revolutionizing diagnostics and precision medicine.HERRO, created by an international team led by the A*STAR Genome Institute of Singapore, utilizes deep learning to rectify errors in nanopore sequencing reads from Oxford Nanopore Technologies (ONT). This technology is particularly valuable for reading long DNA sequences, which are essential for analyzing comple